RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 59 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,877 | -7.0% | 4,580 | -19.9% | 0.00% | – |
| Q2 2023 | $37,491 | +396.0% | 5,715 | +352.1% | 0.00% | – |
| Q1 2023 | $7,559 | +156.8% | 1,264 | +0.1% | 0.00% | – |
| Q4 2022 | $2,943 | -26.4% | 1,263 | +0.1% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 1,262 | +1.5% | 0.00% | – |
| Q2 2022 | $3,000 | -81.2% | 1,243 | -76.8% | 0.00% | – |
| Q1 2022 | $16,000 | -76.5% | 5,364 | -32.8% | 0.00% | – |
| Q4 2021 | $68,000 | – | 7,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $7,083,000 | 7.27% |
| Abingworth LLP | 2,073,957 | $6,077,000 | 1.72% |
| Aisling Capital Management LP | 886,075 | $2,605,000 | 1.41% |
| Novo Holdings A/S | 3,430,377 | $10,085,000 | 0.53% |
| NEA Management Company, LLC | 4,786,921 | $14,073,000 | 0.41% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 700,000 | $2,058,000 | 0.12% |
| Rock Springs Capital Management LP | 1,143,185 | $3,361,000 | 0.08% |
| Ikarian Capital, LLC | 185,597 | $546,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $294,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,648 | $52,000 | 0.00% |